Literature DB >> 10581033

Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification.

Y P Li1, W Chen, Y Liang, E Li, P Stashenko.   

Abstract

Solubilization of bone mineral by osteoclasts depends on the formation of an acidic extracellular compartment through the action of a V-proton pump that has not yet been characterized at the molecular level. We previously cloned a gene (Atp6i, for V-proton pump, H+ transporting (vacuolar proton pump) member I) encoding a putative osteoclast-specific proton pump subunit, termed OC-116kD (ref. 4). Here we show that targeted disruption of Atp6i in mice results in severe osteopetrosis. Atp6i-/- osteoclast-like cells (OCLs) lose the function of extracellular acidification, but retain intracellular lysosomal proton pump activity. The pH in Atp6i-/- liver lysosomes and proton transport in microsomes of Atp6i-/- kidney are identical to that in wild-type mice. Atp6i-/- mice exhibit a normal acid-base balance in blood and urine. Our results demonstrate that Atp6i is unique and necessary for osteoclast-mediated extracellular acidification.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581033     DOI: 10.1038/70563

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  137 in total

1.  Novel treatments for osteoporosis.

Authors:  E Canalis
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  Acid phosphatases.

Authors:  H Bull; P G Murray; D Thomas; A M Fraser; P N Nelson
Journal:  Mol Pathol       Date:  2002-04

3.  When developmental biology meets human pathology.

Authors:  G Karsenty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

Review 4.  Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis.

Authors:  J Lam; Y Abu-Amer; C A Nelson; D H Fremont; F P Ross; S L Teitelbaum
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 5.  New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.

Authors:  J C Crockett; D J Mellis; D I Scott; M H Helfrich
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

Review 6.  Subunit structure, function, and arrangement in the yeast and coated vesicle V-ATPases.

Authors:  Takao Inoue; Stephan Wilkens; Michael Forgac
Journal:  J Bioenerg Biomembr       Date:  2003-08       Impact factor: 2.945

7.  V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.

Authors:  De-Qin Yang; Shengmei Feng; Wei Chen; Haibo Zhao; Christie Paulson; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

8.  The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.

Authors:  W Chen; B Gao; L Hao; G Zhu; J Jules; M J MacDougall; J Wang; X Han; X Zhou; Y-P Li
Journal:  J Periodontal Res       Date:  2016-01-11       Impact factor: 4.419

9.  Cbfβ governs osteoblast-adipocyte lineage commitment through enhancing β-catenin signaling and suppressing adipogenesis gene expression.

Authors:  Mengrui Wu; Yiping Wang; Jian-Zhong Shao; Jue Wang; Wei Chen; Yi-Ping Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-01       Impact factor: 11.205

Review 10.  Recent advances in osteoclast biology.

Authors:  Takehito Ono; Tomoki Nakashima
Journal:  Histochem Cell Biol       Date:  2018-02-01       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.